Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US9233112 | LUPIN LTD | Pharmaceutical compositions of cefixime |
Dec, 2028
(5 years from now) |
Market Authorisation Date: 20 February, 2013
Treatment: Methods for treating bacterial infections
Dosage: FOR SUSPENSION;ORAL
3
United States
2
India
1
Germany
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic